Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.362,24
0,59%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sonnet BioTherapeutics Holdings Inc (SONN) Sonnet BioTherapeutics Holdings Inc (SONN) Notizie

SONN

Sonnet BioTherapeutics (SONN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SONN
DataOraFonteTitoloSimboloCompagnia
12/11/202415:15GlobeNewswire Inc.Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” SegmentNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
08/11/202414:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/11/202415:22Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202419:20GlobeNewswire Inc.Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202415:22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug CandidatesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/10/202414:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/10/202414:45GlobeNewswire Inc.Sonnet BioTherapeutics Inc. Regains Compliance with NasdaqNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/10/202414:45GlobeNewswire Inc.Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in IndiaNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/10/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive ProgramsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/09/202415:00GlobeNewswire Inc.Sonnet BioTherapeutics Announces Launch of CEO Corner PlatformNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
25/09/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock SplitNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
18/09/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid TumorsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/09/202415:15GlobeNewswire Inc.Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell SeriesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202423:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202423:27Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202414:45GlobeNewswire Inc.Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic CancerNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/08/202414:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/08/202414:35GlobeNewswire Inc.Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/08/202423:28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
24/07/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 StudyNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
15/07/202423:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
20/06/202414:30GlobeNewswire Inc.Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross ProceedsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
13/06/202414:00GlobeNewswire Inc.Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 DomainNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/05/202414:00GlobeNewswire Inc.Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual MeetingNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
02/01/202422:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/12/202322:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/12/202323:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/10/202302:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SONN

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network